Top 50 Life Science VC Funds & Investors in Spain (September 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Centre for the Development of Industrial Technology (CDTI)
VC Fund
|
9 | Spain, United States, France | Grant, Seed | Biotechnology, Health Care, Software | $167k–$15M |
|
Bullnet Capital
VC Fund
|
8 | Spain, United States, Mexico | Seed, Series A | Software, Manufacturing, Information Technology | $567k–$11M |
|
BeAble Capital
VC Fund
|
7 | Spain, Italy | Pre-Seed, Seed | Biotechnology, Manufacturing, Software | $132k–$1.2M |
|
Capital Cell
VC Fund
|
7 | Spain, France, United States | Equity Crowdfunding, Seed, Venture - Series Unknown | Health Care, Biotechnology, Medical | $138k–$3.9M |
|
Invivo Capital Partners
VC Fund
|
6 | Spain, France, Belgium | Seed, Series A | Biotechnology, Pharmaceutical, Health Care | $1.6M–$70M |
|
Inveready
VC Fund
|
5 | Spain, United States, United Kingdom | Seed, Series A | Software, Biotechnology, Information Technology | $400k–$14M |
|
Asabys Partners
VC Fund
|
5 | Spain, France, Belgium | Series A, Series B, Seed | Health Care, Biotechnology, Medical Device | $1.3M–$135M |
|
CDTI Innovación's INNVIERTE program
VC Fund
|
4 | Spain, Panama, Switzerland | Venture - Series Unknown, Seed, Grant | Biotechnology, Health Care, Medical | $260k–$16M |
|
Nara Capital
VC Fund
|
4 | Spain | Seed, Venture - Series Unknown, Series A | Life Science, Biotechnology, Medical | $394k–$7.3M |
|
ENISA
VC Fund
|
4 | Spain, United States, France | Seed, Debt Financing, Pre-Seed | Software, Health Care, Artificial Intelligence | $67k–$1.6M |
|
INNVIERTE ECONOMIA SOSTENIBLE SICC SME SA
VC Fund
|
3 | Spain | Series A, Venture - Series Unknown, Grant | Semiconductor, Life Science, Manufacturing | $390k–$3.2M |
|
Alta Life Sciences
VC Fund
|
3 | Spain, United States | Series A, Venture - Series Unknown, Series B | Biotechnology, Health Care, Therapeutics | $3M–$87M |
|
Ysios Capital
VC Fund
|
3 | Spain, United States, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $3.8M–$135M |
|
Fund+
VC Fund
|
3 | Belgium, United States, Spain | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $11M–$401M |
|
Speedinvest
VC Fund
|
2 | United Kingdom, Germany, Austria | Seed, Series A, Pre-Seed | Software, FinTech, Financial Services | $411k–$33M |
|
BoxOne Ventures
VC Fund
|
2 | Canada, United States, United Kingdom | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Software | $281k–$115M |
|
European Investment Bank
VC Fund
|
2 | France, Germany, The Netherlands | Debt Financing, Post-IPO Debt | Biotechnology, Health Care, Energy | $16M–$636M |
|
Grow Venture Partners
VC Fund
|
2 | Spain, Sweden | Seed, Pre-Seed, Venture - Series Unknown | Health Care, Software, Biotechnology | $106k–$9.5M |
|
Criteria Venture Tech
VC Fund
|
2 | Spain, United States, United Kingdom | Seed, Series A | Software, Biotechnology, E-Commerce | $292k–$21M |
|
Charme Capital Partners
VC Fund
|
2 | Spain, Italy, United States | Private Equity, Series A | Health Care, Medical, Medical Device | $5.6M–$20M |
|
CDTI
VC Fund
|
2 | Spain, United States, Mexico | Venture - Series Unknown, Seed | Software, Information Technology, Health Care | $314k–$5.4M |
|
Inveniam
VC Fund
|
2 | Spain | Seed, Grant | Biopharma, Health Care, Life Science | $568k–$1.1M |
|
Josep Carreras Leukaemia Research Institute
VC Fund
|
2 | Spain | Seed | Life Science, Biotechnology | $3.6M–$7.3M |
|
Criteria Bio Ventures
VC Fund
|
2 | United Kingdom, Spain | Seed, Pre-Seed, Series A | Biotechnology, Life Science, Medical | $3.5M–$83M |
|
Talis Capital
VC Fund
|
2 | United Kingdom, United States, Germany | Series A, Seed, Series B | Software, Information Technology, E-Commerce | $1M–$30M |
|
Demium Capital
VC Fund
|
2 | Spain, Portugal, Poland | Pre-Seed, Seed, Series A | Software, Information Technology, Artificial Intelligence | $110k–$3.1M |
|
Xesgalicia
VC Fund
|
2 | Spain, Portugal | Seed, Venture - Series Unknown | Software, Biotechnology, B2B | $289k–$5.9M |
|
Amino Collective
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Artificial Intelligence | $125k–$37M |
|
Monte Carlo Capital
VC Fund
|
2 | United States, United Kingdom, Switzerland | Seed, Series A | Artificial Intelligence, FinTech, Software | $375k–$100M |
|
BStartup - Banc Sabadell
VC Fund
|
2 | Spain, Mexico, United States | Seed, Pre-Seed | Software, Information Technology, Artificial Intelligence | $110k–$2M |
|
Clave Capital
VC Fund
|
2 | Spain, Chile, Switzerland | Seed, Series A, Venture - Series Unknown | Biotechnology, Software, Health Care | $462k–$21M |
|
Amadeus Capital Partners
VC Fund
|
2 | United Kingdom, United States, Spain | Series A, Seed, Series B | Software, Artificial Intelligence, Information Technology | $800k–$56M |
|
GGF
VC Fund
|
1 | Germany, United States, United Kingdom | Seed, Series A, Pre-Seed | Food and Beverage, Manufacturing, Food Processing | $2M–$22M |
|
General Inception
VC Fund
|
1 | United States, Spain, France | Seed, Pre-Seed | Biotechnology, Life Science, Genetics | |
|
Reig Jofre
VC Fund
|
1 | Spain | Medical, Biopharma, Life Science | ||
|
BCN PEPTIDES
VC Fund
|
1 | Spain | Medical, Biopharma, Life Science | ||
|
SeedBlink
VC Fund
|
1 | Romania, United States, United Kingdom | Seed, Pre-Seed, Series A | Software, Information Technology, SaaS | |
|
Santander
VC Fund
|
1 | Spain, United Kingdom, United States | Debt Financing, Post-IPO Debt, Seed | Energy, Renewable Energy, Financial Services | $100k–$1.5B |
|
Pontifax
VC Fund
|
1 | United States, Israel, France | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6.3M–$130M |
|
Gilde Healthcare
VC Fund
|
1 | United States, The Netherlands, Germany | Series B, Series C, Series A | Health Care, Biotechnology, Medical | $9.5M–$135M |
|
Alma Mundi Ventures
VC Fund
|
1 | Spain, United States, United Kingdom | Series A, Seed | Software, Insurance, InsurTech | |
|
Addition
VC Fund
|
1 | United States, India, Brazil | Series A, Series B, Series C | Software, FinTech, Financial Services | |
|
Veg Capital
VC Fund
|
1 | United Kingdom, Brazil, Sweden | Seed, Equity Crowdfunding, Pre-Seed | Food and Beverage, Organic Food, Food Processing | $213k–$10M |
|
Grupo Ferrer Internacional
VC Fund
|
1 | Spain | Series A | Biotechnology, Wellness, Biopharma | |
|
Debiopharm Innovation Fund
VC Fund
|
1 | Switzerland, United States, France | Series A, Seed, Pre-Seed | Health Care, Biotechnology, Software | $317k–$25M |
|
Alantra
VC Fund
|
1 | Spain, Sweden, France | Private Equity, Debt Financing, Series B | Energy, Manufacturing, Financial Services | $7.7M–$39M |
|
Global health sciences venture fund
VC Fund
|
1 | United States, Canada, Spain | Series C, Series A, Series B | Biotechnology, Health Care, Therapeutics | $10M–$72M |
|
Innova-Tech Consulting
VC Fund
|
1 | Canada, Spain | Series A, Seed, Series B | Solar, Energy, Medical | $1.8M–$16M |
|
UCB Ventures
VC Fund
|
1 | United States, Belgium, Spain | Series A, Series B, Seed | Biotechnology, Health Care, Medical | $1.8M–$135M |
|
Nina Capital
VC Fund
|
1 | United States, United Kingdom, Germany | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $529k–$21M |
| Access all 153 VC funds in Spain Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Grant, Seed
- Geography: Spain, United States, France
Investor stats
- Total investments: 221
- Round size: Seed $576k–$5.8M; Grant $167k–$15M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- FuVeX — FuVeX is dedicated to the design, manufacture, and commercialization of drones. The vision of the members of FuVeX is to improve the way in which the great institutions and companies are related to the aeronautics. Moreover, the company's mission is to provide such institutions and companies with an aircraft that allows them to solve theirmonitoring or transportation needs by flying long distances in a safe, easy and legal way.
- Orga AI — Organ AI creates generative artificial intelligence that will help people. Its headquarters is located in Palma De Mallorca, Islas Baleares, Spain.
- Phoenix Foods — Phoenix Foods uses insect farming to solve the problems of organic waste management and the requirement for high-quality proteins in animal feed.
Independent Venture Capital Firm specialized in high technology Spanish start-ups. Helping tech entrepreneurs during the early stages of their company to build successful businesses
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Series A
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 68
- Round size: Seed $1M–$3.2M; Series A $567k–$11M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — raised $87M in 2023
Portfolio highlights
- FlexiiC — Reinventing the world of electronics with a revolutionary organic and flexible technology that enables a new generation of sensors and logic based on solution deposited functional inks at a low temperature, on low-cost substrates to make organic integrated circuits. Products and services FlexiiC presents design modeling services including Application Specific Integrated Circuits (ASIC) and Process ... Read more
- Bioherent — Photonic biosensors for drug allergy diagnosis
- Impetux Optics — Impetux is a worldwide key manufacturer and supplier of turnkey optical tweezers systems designed for mechanobiology studies in living cells and 3D tissues.
BeAble Capital is a Science Equity Fund, therefore it is a pre-seed, seed and early stage venture capital management company specialized in the identification, valuation, launch and development of technologies in the sectors of advanced materials (nanotechnology and biotechnology), photonics, micro and nano electronics and Information andcommunications technologies (ICT) platforms.It acts as the link between scientific, entrepreneurial and investing worlds to promote the transfer of technology, the creation and the development of technology-based companies (start-ups) from private equity. The company is focused on strong intelectual property and long R&D background projects. Their work provide value at different stages of development by offering support in strategic points such as the identification of technologies, valuation, transfer, companies creation, fundraising, marketing, internationalization and administrative and managerial expertise.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Software
- Stage:Pre-Seed, Seed
- Geography: Spain, Italy
Investor stats
- Total investments: 70
- Round size: Seed $158k–$1.2M; Pre-Seed $132k–$514k
- Lead/follow: 83% lead, 17% follow
- Last fund: May invest from a new fund soon — raised $39M in 2016
Portfolio highlights
- Molecular Gate — Transformative Anti-Counterfeiting Technology. Multifunctional Level 1 Anti-Counterfeit Solutions: See-through Polargram and Reflective Polargram
- Bioinspired Materials — Bioinspired Materials is a Biotech-based entrepreneurship project with the participation of the Universitat Pompeu Fabra. The company develops wastewater valorization that produces biological products of high value in the market. BIOM was founded in 2019 and is based in Barcelona, Spain.
- Ars Magna Semiconductors — Ars Magna Semiconductors develops semiconductor chips designed for decentralized artificial intelligence applications. The company's technology operates with low energy consumption, real-time processing, and enhanced data privacy by reducing the number of operations and hardware requirements. Their chips address the global semiconductorshortage while enabling more efficient AI processing with reduced computational overhead.
Capital Cell is a crowdinvesting platform for biotech and life sciences companies. Mixing VC, business angels, accredited investors, and the power of the crowd, the company is building a global meeting point for companies and researchers working, fostering, and financing tomorrow’s medical science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Equity Crowdfunding, Seed, Venture - Series Unknown
- Geography: Spain, France, United States
Investor stats
- Total investments: 52
- Round size: Seed $392k–$1.9M; Equity Crowdfunding $138k–$1.5M; Venture - Series Unknown $617k–$3.9M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- DYNAMICS VR — Dynamics VR provides rehab software for clinics to tackle musculoskeletal pain and movement impairments caused by brain trauma.
- Axoltis Pharma — Axoltis Pharma is a biotech company that develops drugs for degenerative and traumatic neurological disorders.
- EVis Bioscience — EVis Bioscience develops innovative gene delivery systems for targeted and personalized medicine. This includes extracellular vesicles, synthetic lipid nanoparticles, and their hybrids.
Invivo Capital is a team of knowledgeable professionals with the scientific, technical, and financial know-how required to analyze and make investments that provide value to the invested company. They also have a network of contacts and key strategic relationships in the health ecosystem.
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Health Care
- Stage:Seed, Series A
- Geography: Spain, France, Belgium
Investor stats
- Total investments: 35
- Round size: Seed $1.6M–$13M; Series A $2.2M–$70M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $44M in 2019
Portfolio highlights
- Signadori Bio — Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the creation of a groundbreaking biotech venture in the cell and gene space that is set to advance innovative approaches in oncology.
- ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
- Telum Therapeutics — Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages.
Inveready is a leading Spanish financial services firm focused on investment solutions and wealth management.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 254
- Round size: Seed $400k–$5.5M; Series A $1.6M–$14M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $63M in 2024
Portfolio highlights
- Dolfin — The first agentic sales commission platform. Automate payouts, drive rep motivation, and eliminate the Black Box.
- Inventia Kinetics — Inventia Kinetics specializes in the design, analysis, and manufacture of equipment and assembly tools for electronics sector.
- Telum Therapeutics — Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages.
Fostering breakthrough innovation in healthcareAsabys is an investment firm based in Barcelona, investing in healthcare and life-sciences innovation. PORTFOLIO TEAM Impact We want to push the boundaries of science and medicine improving patient's life Disruptive We look for highly innovative and transformative technologies Hands-on We consider ourselves partners and collaborators to our portfolio
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Seed
- Geography: Spain, France, Belgium
Investor stats
- Total investments: 38
- Round size: Seed $1.3M–$13M; Series A $7M–$57M; Series B $18M–$135M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely still investing — raised $117M in 2022
Portfolio highlights
- Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
- Oriva Therapeutics — Oriva Therapeutics is a women's health company that treats chronic conditions affecting women.
CDTI Innovación's INNVIERTE program is part of the Spanish Science, Technology, and Innovation Strategy. This Strategy is one of the cornerstones around which the Government's R&D&I strategy for the upcoming years is built. It outlines the goals, changes, and actions that must be implemented across the R&D&I sector inorder to maximize its growth and effect.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Venture - Series Unknown, Seed, Grant
- Geography: Spain, Panama, Switzerland
Investor stats
- Total investments: 53
- Round size: Seed $266k–$6.4M; Grant $260k–$1.1M; Venture - Series Unknown $330k–$16M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Ancavico — Ancavico is a seafood production company that offers deep-frozen products, fish, cephalopods, seafood mixes, and salads.
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
- Telum Therapeutics — Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages.
As asset managers, we invest on behalf of third parties. Our fear of losing their money is greater than the fear of losing an opportunity. Our investment style consists of value orientation, specialization and trust, applying our investment criteria in a disciplined way. We invest to transform the companies into industry leaders. With a hands-onapproach, Nara invests in assets enhancing its value with a long-term view. We are a highly experienced team with the patience and tenacity required to see deals through, committing our own money. We create value in a sustainable way, investing in a responsible way to generate a positive impact on the community. We analyze each investment in detail in order to create shared value for our investors, partners, customers, suppliers and workers.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Spain
Investor stats
- Total investments: 10
- Round size: Seed $394k–$7.3M; Venture - Series Unknown $1.9M–$3.3M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Aortyx — With a focus on aortic dissection, Aortyx has developed a bioresorbable endovascular patch designed to seal the entry tear, delivered through a proprietary dual-steerable catheter.
- MiMARK — MiMARK specializes in developing in vitro diagnostic solutions to improve the management of gynecological malignancies. The company envisions the gynecological fluid as the next step in liquid biopsy in gynecology. MiMARK 's first objective is to improve endometrial cancer diagnosis.
- Neboda — We are an indoor vertical farming company that combines combines a scientific approach and an industrial automation background.
ENISA is a public company under the Ministry of Industry, Energy and Tourism, through the Directorate General of Industry and Small and medium-sized enterprises which, since 1982, actively participates in the financing of viable and innovative business projects.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Debt Financing, Pre-Seed
- Geography: Spain, United States, France
Investor stats
- Total investments: 236
- Round size: Seed $76k–$1.6M; Pre-Seed $165k–$1.2M; Debt Financing $67k–$489k
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Naturr — Nature, which seeks to connect small-scale artisanal food producers from rural areas with urban consumers. Nature platform could serve as an important bridge for promoting local and sustainable food systems, benefiting both rural producers and urban consumers i
- Biotasmart — Plataforma que convierte datos de la microbiota intestinal en recomendaciones nutricionales personalizadas.
- DARWIN Biomed — Biomedical Engineering
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!CDTI
Show more...Investment focus
- Industry: Semiconductor, Life Science, Manufacturing
- Stage:Series A, Venture - Series Unknown, Grant
- Geography: Spain
Investor stats
- Total investments: 13
- Round size: Series A $390k–$1.4M; Venture - Series Unknown $1.6M–$3.2M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Basquevolt — Basquevolt is a leader in solid state battery technology.
- FYLA — FYLA designs ultrafast fiber lasers, combining precision engineering and quality. Discover supercontinuum and femtosecond laser solutions.
- A4CELL — A4CELL is a company that develops SPAchip (suspended planar-array chips) that help monitor living single cells. They offer SPAchips, as well as the CytoCHECK SPAchip and the CytoCHECK SPAchip. The company's goal is to increase the accuracy and quality of cell study data in order to better understand disease behavior.
Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Venture - Series Unknown, Series B
- Geography: Spain, United States
Investor stats
- Total investments: 18
- Round size: Series A $3M–$34M; Series B $13M–$87M; Venture - Series Unknown $3.3M–$14M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Spain, United States, Switzerland
Investor stats
- Total investments: 84
- Round size: Series A $3.8M–$65M; Series B $17M–$135M; Series C $29M–$83M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $246M in 2020
Portfolio highlights
- Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
- AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
- Inbiomotion — Inbiomotion is focused on the development and commercialization of a biomarker that predicts metastasis to improve patients' quality of life by personalizing the adjuvant treatment of early stage breast cancer. Founded in 2010 by Dr. Roger Gomis, it is a spin-off of IRB Barcelona and ICREA research institutions.Inbiomotion's uniquediagnostic assay is based on a highly selective single gene biomarker. Data generated thus far suggests such biomarker can identify early stage breast cancer patients that will benefit from bisphosphonate adjuvant treatment improving their overall and invasive disease free survival. It can further predict at an early stage a patient's risk of metastases relapse from primary tumors. The selectivity of the lead biomarker has the potential to advance the clinical standard of care using personalized medicine.
Fund+ is a venture capital firm that invests in companies operating in the diagnostics, therapeutics, medical devices, and life science sectors. The firm wants to create sustainable shareholders' value, contribute to the development of a leadership position in the life sciences sector, and generate a tangible, beneficial societal impact.Fund+ was established in 2015 and is based in Leuven, Belgium.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: Belgium, United States, Spain
Investor stats
- Total investments: 34
- Round size: Series A $12M–$47M; Series B $22M–$125M; Series C $11M–$401M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
- Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
- TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Speedinvest is a globally active European venture capital firm built on a simple belief: many move more. From six offices across EMEA, our sector-focused investment teams back relentless founders from pre–Seed to Growth with long-term conviction, providing day-one access to our global network of corporate customers, experts, industry leaders, andtop-tier follow-on investors to scale smarter and faster. Building lasting companies like Bitpanda (Austria), Moove (Nigeria), Gigs (U.S.), Tide (UK), ARX Robotics (Germany), Wayflyer (Ireland), GoStudent (Austria), Seqera Labs (Spain), and Cylib (Germany) — together. Big ideas may start with one. But scaling and winning take The Power of More.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, Germany, Austria
Investor stats
- Total investments: 662
- Round size: Seed $798k–$7.9M; Pre-Seed $411k–$3.8M; Series A $4.1M–$33M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $372M in 2022
Portfolio highlights
- Findery — Find and leave notes anywhere in the world, discover local knowledge, hidden secrets, and exciting stories. Share your travel knowledge, geoblog, or local news!
- GAMINSIDE — GAMINSIDE revolutionizes your relationship with your customers. As European full service provider, we deliver the complete package with solutions, services and software for gamified loyalty that is tailor-made and unique to your products, brands and customers. Integrate the best ideas from gamification and customer loyalty in your business areato exceed your commercial targets with GAMINSIDE.
- Polaron — Material Design. Supercharged with AI.
BoxOne Ventures is a privately held investment firm that focuses on early-stage companies across the most impactful, interesting and fast-changing sectors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 69
- Round size: Seed $1.3M–$9.5M; Pre-Seed $281k–$2M; Series A $744k–$115M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Dispersa — Harnessing the power of microbe-derived natural solutions to decarbonize the chemicals industry.
- Opalia — Opalia is introducing a new era of dairy: functional, delicious, and sustainable dairy made from mammary cells.
- Thred — Thred is the first B2B Intent platform designed for AI. Act on accounts researching in ChatGPT, Gemini, and Claude.
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Energy
- Stage:Debt Financing, Post-IPO Debt
- Geography: France, Germany, The Netherlands
Investor stats
- Total investments: 571
- Round size: Post-IPO Debt $16M–$636M; Debt Financing $16M–$345M
- Lead/follow: 83% lead, 17% follow
Portfolio highlights
- Oceanloop — Oceanloop uses cutting-edge aquaculture technologies to transform the worldwide shrimp industry. Land-based Oceanloop shrimp farms provide high-quality, antibiotic-free, and sustainable saltwater shrimp production where consumption occurs. When compared to conventional farms, Oceanloop considerably reduces its resource utilization and environmentalfootprint.
- Wandercraft — Self- balancing and hands free movement with the innovative self-balancing feature, Atalante allows for multi-tasking and cognitive involvement as part of treatments.
- Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
Venture Capital for Entrepreneurs with seasoned experts and advisors to succed in creating value in a meaningful way. Coaching and Mentoring Ideas People
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Spain, Sweden
Investor stats
- Total investments: 27
- Round size: Seed $549k–$9.5M; Pre-Seed $106k–$2.5M; Venture - Series Unknown $218k–$794k
- Lead/follow: 59% lead, 41% follow
- Last fund: Likely actively investing — fresh fund, raised $11M in 2024
Portfolio highlights
- Tirecat — Tirecat specialized in developing sophisticated tissue regeneration treatments to combat chronic and terminal diseases.
- X1 Wind — X1 Wind is a disruptive innovative floating wind platform with the potential to make a step change in offshore wind.
- NSS Water — NSS Water specializes in innovative water purification technology for high-tech sectors such as semiconductors.
Criteria Venture Tech is the tech VC fund of CriteriaCaixa which invests in B2B SaaS and DeepTech companies in early and growth stages (Seed to Series B) managing more than €300M of AUM.
Show more...Investment focus
- Industry: Software, Biotechnology, E-Commerce
- Stage:Seed, Series A
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 165
- Round size: Seed $292k–$3.8M; Series A $1.9M–$21M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely actively investing — fresh fund, raised $140M in 2026
Portfolio highlights
- 8Layers — 8Layers is an artificial intelligence platform that offers cloud identity threat detection to organizations
- Barbara — Barbara is the Cybersecure Industrial Edge Platform that enables companies to connect, deploy and scale gateways and edge applications in a few clicks
- iPronics — iPronics develops the innovative concepts of general-purpose integrated programmable photonic systems.
Charme Capital Partners is a European mid-market private equity fund, supporting management teams and shareholders to achieve transformational change, growth and internationalisationFrom our offices in Milan, London and Madrid we invest in businesses across Europe with an enterprise value of €100m to €500mContinuous interaction with ourinvestor base is key in sourcing new opportunities, testing investment theses and growing portfolio companies
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Private Equity, Series A
- Geography: Spain, Italy, United States
Investor stats
- Total investments: 7
- Round size: Series A $5.6M–$20M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $596M in 2021
Portfolio highlights
- Bianalisi — Bianalisi provides services that include toxicological examination of the hair, diagnostic imaging, specialised examinations, laboratory analysis, physiotherapy and rehabilitation, occupational medicine, and more. They offer diagnostic services.
- UNIVERSAE — UNIVERSAE offers vocational training services.
- Prism Healthcare — Transforming LivesA leading integrated solutions provider dedicated to transforming lives in the paediatric, home, and long-term care sectors. About Prism Healthcare Group Transforming Lives When health or mobility declines, the...
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Developing combustion engine catalyst and coating technology to reduce emissions and improve fuel efficiency for clean energy production.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Venture - Series Unknown, Seed
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 37
- Round size: Seed $314k–$2.8M; Venture - Series Unknown $765k–$5.4M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
- PLD Space — PLD Space is a spanish innovative start-up company is to provide low cost and high reliability access to space. PLD Space offers suborbital and orbital launch services to its clients.
- Atlas Molecular Pharma — Latest News Your browser does not support the video tag.
Strategic consulting for meaningful innovations in health, sustainability and deep tech.
Show more...Investment focus
- Industry: Biopharma, Health Care, Life Science
- Stage:Seed, Grant
- Geography: Spain
Investor stats
- Total investments: 4
- Round size: Seed $568k–$1.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AtG Therapeutics — At AtG, we develop new drugs and biomarkers to stop cancer metabolic adaptation.
- NIMBLE Diagnostics — NIMBLE Diagnostics is a technological organization that develops and provides services related to biotechnology research activities.
International research Institute that pursues to study and eradicate Leukaemia, Lymphoma and other Hemopathies.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Seed
- Geography: Spain
Investor stats
- Total investments: 2
- Round size: Seed $3.6M–$7.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies
Supporting life-changing therapies through long-term strategic partnerships
Show more...Investment focus
- Industry: Biotechnology, Life Science, Medical
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, Spain
Investor stats
- Total investments: 7
- Round size: Pre-Seed $3.5M–$3.5M; Series A $29M–$83M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- NRG Therapeutics — energizing drug discovery in neurodegenerative diseases.
- Adaptam Therapeutics — Pioneering cancer immunotherapies targeting the immunosuppressive myeloid tumor microenvironment for the treatment of solid tumors.
- Cytospire Therapeutics — Cytospire Therapeutics is bringing forward a portfolio of next generation immune cell engagers.
We back founders who see the future differently.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Series A, Seed, Series B
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 84
- Round size: Seed $1M–$15M; Series A $3M–$22M; Series B $10M–$30M
- Lead/follow: 54% lead, 46% follow
- Last fund: Likely still investing — raised $175M in 2023
Portfolio highlights
- CensorNet — CensorNet can help your organisation manage the rise of cloud applications in an increasingly mobile world. Our solutions let you see, control and protect all internet activity and the use of cloud applications across all devices. We protect your users, whether they are in the office or on the road.With this protection, you can embrace cloudapplications, safely implement BYOD initiatives and control shadow IT.
- Pass the Keys — Pass the Keys is an airbnb management company offers an expert Airbnb and short let management service. They create opportunities in every corner of the world, for their hosts, their guests and their people.The UK’s largest professional co-host they list your property on platforms like Airbnb, so you don’t have to. Offering a fully-managedservice, Pass the Keys even finds, manages, and cleans up after your guests. With HQ in London and further satellite offices in all of their cities in the UK, they use tech to increase the money landlords are getting back from their property and manage those properties efficiently and effectively. What this means if you’re a landlord is more money and less work.
- Rubi Laboratories — Rubi Laboratories turns carbon emissions into carbon-negative textiles for the fashion industry, with a proprietary synthetic biology technology.
Demium is a talent investment company founded in Spain in 2013 with the aim of supporting the best professionals and helping them to carry out successful projects, always with an eminently digital and technological component. In November 2020, it's asset management company, Demium Capital, started operating with a first €50M fund to invest inmore than 75 early-stage startups per year (pre-seed/seed), becoming the most active venture capital fund in Spain. Startups such as Hannun, Voicemod, Swipcar, Citibox, Singularu or Landbot, among others have been created in the incubator. The company is present in five countries: Spain, Portugal, Poland, Ukraine and Czech Republic
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Pre-Seed, Seed, Series A
- Geography: Spain, Portugal, Poland
Investor stats
- Total investments: 85
- Round size: Seed $113k–$3.1M; Pre-Seed $110k–$574k
- Lead/follow: 61% lead, 39% follow
- Last fund: May invest from a new fund soon — raised $59M in 2020
Portfolio highlights
- Rauda AI — Rauda is an artificial intelligence platform specialized in automating customer service with the best customer experience. Take a quantum leap in productivity, reduce costs and improve customer satisfaction with the power of generative artificial intelligence.
- Aino — AI-powered spatial analytics platform for architecture, urban planning and development teams. Site analysis, GIS-free mapping and location intelligence. 400+ cities covered.
- Orbital Paradigm — Orbital Paradigm builds reusable vehicles that carry cargo to space and bring it back. Dedicated missions, any orbit, on your schedule. Based in Madrid.
XesGalicia is a Galician Venture Capital Management firm. It finances company development through the temporary acquisition of minority shares of the capital of unquoted companies.
Show more...Investment focus
- Industry: Software, Biotechnology, B2B
- Stage:Seed, Venture - Series Unknown
- Geography: Spain, Portugal
Investor stats
- Total investments: 34
- Round size: Seed $289k–$5.9M; Venture - Series Unknown $904k–$5.5M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.
- VigSec-Drone — VigSec-Drone is a high-performance security and surveillance designed to deliver real-time situational awareness.
- Iteria Biopharma — PROFESSIONAL TEAM User can utilize his smartphone to pay for a wide range of services or any CONSULTATION User can utilize his smartphone to pay for a wide range of services or any TREATMENT User can utilize his smartphone to pay for a wide range of services or any First-in-class NCEs addressed to modulate challenging
Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 45
- Round size: Seed $2.4M–$14M; Pre-Seed $125k–$7.8M; Series A $12M–$37M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Calibre — Diagnostic testing, clinicians, and AI working together to help you deeply understand your health and how to improve it.
- Modern Relay — Modern Relay provides context graph for enterprise AI.
- Theorema — We build causal disease models to help pharmaceutical and biotech companies find promising drug targets and new indications for existing assets.
Discover Monte Carlo Capital, a leading angel investment firm supporting early-stage startups in technology.
Show more...Investment focus
- Industry: Artificial Intelligence, FinTech, Software
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 67
- Round size: Seed $375k–$9.3M; Series A $1.3M–$100M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely actively investing — fresh fund, raised $13M in 2025
Portfolio highlights
- Algorized — Algorized develops advanced technologies for human presence detection using UWB Radar.
- Ratio — A new way to finance subscription companies without dilution offering flexibility to help you thrive and compete. Put your recurring revenue to work.
- Scout AI — Scout AI is building the robotic foundation model for defense.
A Banc Sabadell initiative to support young companies in developing their projects. Bstartup is designed to support entrepreneurs so their projects can be developed with maximum guarantees of success. - Investment and growth - Specialized products and branches - Collaborative innovation
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: Spain, Mexico, United States
Investor stats
- Total investments: 87
- Round size: Seed $110k–$2M; Pre-Seed $219k–$900k
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- TietAI — TietAI is the agentic integration layer for hospitals, payers and digital health, unifying HL7, FHIR, X12 and DICOM into one governed plane.
- Energiot — Energiot specialized engineering service in energy harvesting, self-powered devices, wireless sensor networks.
- Floatech — Discover Floatech: Boosting lithium-ion batteries with sustainable, high-performance silicon anodes. Explore our innovative technology.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Clave is an investment management company.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Spain, Chile, Switzerland
Investor stats
- Total investments: 51
- Round size: Seed $462k–$4.7M; Series A $3.2M–$21M; Venture - Series Unknown $541k–$7.1M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — raised $53M in 2023
Portfolio highlights
- Sensesbit — Sensesbit is a SaaS market research platform focused on sensory intelligence for the food and beverage industry, developed by TasteLab to analyze and predict product market acceptance . The tool integrates advanced statistical analysis, AI for benchmarking, and computer vision tools to manage sensory testing with consumers and trained panels. Learnmore about the platform on the official Sensesbit website.
- D-Sight — D-Sight is an early treatment for the leading cause of preventable blindness in the working-age population.
- Telum Therapeutics — Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages.
Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series A, Seed, Series B
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 267
- Round size: Seed $800k–$9.2M; Series A $2.6M–$30M; Series B $7.2M–$56M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $85M in 2023
Portfolio highlights
- Tenzo — Tenzo is a restaurant analytics and AI forecasting platform for restaurants, pubs and cafes. Tenzo makes running restaurants easy with full data visibility.
- Slamcore — Positioning, mapping and perception | State-of-the-art visual SLAM turns sensor data into actionable, spatial understanding for your vehicles.
- Respiro Diagnostics — Respiro is harnessing insights from the breath to detect lung cancer earlier, non-invasively, and without scans or radiation. Built for use in everyday care settings.
The Green Generation Fund invests in early stage Food Tech and Green Tech companies that make our lives and diets more sustainable, healthy and ethical.
Show more...Investment focus
- Industry: Food and Beverage, Manufacturing, Food Processing
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 44
- Round size: Seed $2.7M–$16M; Pre-Seed $2M–$3.7M; Series A $3.8M–$22M
- Lead/follow: 64% lead, 36% follow
- Last fund: Likely still investing — raised $104M in 2022
Portfolio highlights
- One.Five — Grow your strategic edge with AI-generated solutions that deliver the ultimate packaging performance, affordability & sustainability
- Planetary — Planetary is a biomanufacturing company that develops and operates fermentation facilities for producing bio-based products at industrial scale. Its platform combines fermentation, AI, and process optimization to support precision fermentation, microbial fermentation, sustainable materials, and mycoprotein production for food and alternativeprotein applications.
- WeSort.AI — WeSort.AI: KI-basierte Abfallsortierung und Systeme zur granularen Analyse von Abfallobjekten. Mehr erfahren.
General Inception partners with inventors to ignite innovation and create transformational companies. We are co-founders bringing together domain expertise, seasoned executive talent, infrastructure resources, and capital to nurture company growth from inception.
Show more...Investment focus
- Industry: Biotechnology, Life Science, Genetics
- Stage:Seed, Pre-Seed
- Geography: United States, Spain, France
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- Biocellis — Biocellis develops ultra-sensitive, bioluminescence-based diagnostics for next-generation immunoassays. Scalable, fast, and point-of-care ready.
- Pharmacelera — Improving pharmaceutical R+D productivity through a lean drug discovery process based on advanced computational methodologies.
- Tavira Therapeutics — Tavira Therapeutics develops an innovative technology that equips AAV vectors with molecules to accurately target the intended tissues.
Reig Jofre is a manufacturer of pharmaceutical products. The company produces drugs, penicillin antibiotics, and other pharmaceutical products.
Show more...Investment focus
- Industry: Medical, Biopharma, Life Science
- Geography: Spain
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
BCNPeptides is dedicated to pioneering R&D in cutting-edge bioactive peptides. We deliver tailor-made, high-quality solutions
Show more...Investment focus
- Industry: Medical, Biopharma, Life Science
- Geography: Spain
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
All-in-one solution for fundraising, managing and trading equity. Explore promising tech startups and flexible funding opportunities with SeedBlink.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Romania, United States, United Kingdom
Investor stats
- Total investments: 103
- Lead/follow: no public data
Portfolio highlights
- Pago — Managing and paying utility bills, insurance, mobile top-ups and taxes takes too much time for many households in Europe. Pago simplifies these payments by adding automation where possible, using integrations with billers, insurers and online platforms to dramatically reduce the time needed for all these payments. The service is available in theB2C app called Pago and through B2B integrations by embedding Pago features in partner apps through SDK or API. Pago's services are used by over 500k monthly active users in Romania, Poland and Italy.
- Brainactive — Brainactive is an AI-driven platform that streamlines the access to vital insights used by companies to make sound business decisions, by enabling them to directly interview their current and potential customers, regardless of their expertize in sociology, past experience with market research, size of their team, or their market research budget.Integrated with a pool of 300+ million vetted and engaged consumers around the world, the platform allows companies to get relevant answers to their questions in minutes, with assistance from advanced conversational and generative LLM trained on market research, available along the way.Putting businesses in direct contact with their customers essentially removes the need for any intermediaries in the process and brings the costs and time down to a mere fraction of what traditional market research typically requires. At the same time, companies get to keep sensitive concepts and prototypes tested entirely secured, since no one else is involved, at any stage.
- dotLumen - Empowering the Blind — .lumen builds glasses that help the blind live a better life.
Our purpose is to help people and businesses prosper. We strive to make all we do Simple, Personal and Fair.
Show more...Investment focus
- Industry: Energy, Renewable Energy, Financial Services
- Stage:Debt Financing, Post-IPO Debt, Seed
- Geography: Spain, United Kingdom, United States
Investor stats
- Total investments: 146
- Round size: Seed $100k–$5.5M; Post-IPO Debt $14M–$1.5B; Debt Financing $16M–$1.4B
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — raised $658M in 2019
Portfolio highlights
- Naturmet — Naturmet is a Spanish company under the Oleofat Group, specializing in the production of biomethane and the valorization of organic waste into biofertilizers. The firm focuses on rural circular economy projects, developing multiple processing sites across Spain for anaerobic digestion and biogenic CO₂ capture.Naturmet has sought to bring a circulareconomy model to rural areas, focused on reducing greenhouse gas emissions and connecting those areas with industry through carbon-neutral or even negative-emission fuels.
- Sonnedix — Sonnedix is an Independent Solar Power Producer (IPP) with a proven track record in delivering high performance cost competitive solar photovoltaic plants to the market.
- BATZ — BATZ is focused on the design and manufacturing of products that help the reduction of CO2 emissions aligned with the main automotive sector trends. Their broad expertise in the design and manufacturing of composite lightweight structures through new materials and processes and active aerodynamic components; together with their qualification andacknowledgement in the design and manufacturing of mechanical and mechatronic control systems, turn BATZ into a first-class supplier to leading automotive OEMs. Besides, they develop solutions for the implementation of new advanced materials improving their forming processes in a comprehensive range of steel and aluminum, both in hot and cold forming, offering a comprehensive service that ranges from the conceptual design of the product to its try out and commissioning.
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 122
- Round size: Series A $6.3M–$110M; Series B $20M–$130M; Series C $22M–$101M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $14M in 2020
Portfolio highlights
- Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
- Otic Pharma — Otic Pharma is a clinical-stage pharmaceutical company focusing on the development and commercialization of products for disorders of the ear, nose, and throat (ENT). The company has two platform technologies, each of which has the potential to be developed for multiple ENT indications. The company is currently developing anasally-administered, combination drug product (OP-02) intended to address the underlying cause of otitis media and Eustachian tube dysfunction (OM/ETD), a condition that affects more than 700 million people around the world every year. Otitis media is one of the most common disease seen in pediatric practice and the most frequent reason children consume antibiotics or undergo surgery. The company also has a foam-based drug delivery technology platform (OP-01) that can be used to deliver drugs into the ear, nose, and sinus cavities. The company is currently developing OP-01 as an improved treatment option for acute otitis externa (“swimmers ear”). For more information on the company, please visit www.oticpharma.com
- Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. It has over €800 million ($900 million) under management and is actively looking to lead new investments in digital health, diagnostics, medical devices, therapeutics and healthcareservices. Gilde successfully builds healthcare businesses across Europe and US, investing up to €35 million in a single portfolio company.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series C, Series A
- Geography: United States, The Netherlands, Germany
Investor stats
- Total investments: 131
- Round size: Series A $9.5M–$62M; Series B $14M–$135M; Series C $21M–$80M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely actively investing — fresh fund, raised $296M in 2026
Portfolio highlights
- Big Health — Our mission is to help millions back to good mental health. Our digital therapeutics are safe and effective non-drug alternatives for mental health.
- GT Medical Technologies — GammaTile is an FDA-cleared, bioabsorbable collagen implant embedded with radiation seeds, designed for patients with operable brain tumors.
- Endovascular Engineering — Endovascular Engineering is a medical technology company focused on developing and deploying advanced clot removal solutions for the treatment of venous thromboembolism. It specializes in thrombectomy technologies designed to improve clinical outcomes and procedural efficiency in minimally invasive vascular interventions. The company’s flagshipinnovation is the Hēlo™ Thrombectomy System, a catheter-based device that uses a combination of mechanical agitation and physician-controlled aspiration to remove blood clots. Its technology emphasizes features such as a self-expanding funnel design and dual-action functionality to enhance clot engagement and navigation through complex anatomies. Endovascular Engineering primarily serves healthcare providers, including interventional cardiologists and radiologists, supporting the treatment of conditions such as pulmonary embolism and deep vein thrombosis.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We back bold and purpose-driven founders.
Show more...Investment focus
- Industry: Software, Insurance, InsurTech
- Stage:Series A, Seed
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 108
- Lead/follow: no public data
Portfolio highlights
- LAIIER — The best LAIIER of defense against liquid leak-driven damage in buildings and industrial equipment.
- Ole Insurance Group — Ole Insurance Group focuses on offering protection and well-being products and services through technology. Ole Insurance Group was founded in 2021 and was headquartered in Puerto Rico.
- Epoch Biodesign — Mellizyme Biotechnology is currently operating in stealth.
We invest in early & growth stage technology companies. We were founded with a mission to support visionaries in building impactful & enduring businesses.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Series A, Series B, Series C
- Geography: United States, India, Brazil
Investor stats
- Total investments: 145
- Lead/follow: no public data
Portfolio highlights
- Render — Deploy and scale any app or agent from your first user to your billionth. Build faster on intuitive cloud infrastructure for the modern web.
- Ernesta — Made to fit your home. Ernesta offers designer quality custom-sized rugs that make you proud of the home you've designed. Shop now.
- Onehouse — Open storage, continuous pipelines, and automatic optimizations across table formats, engines, clouds. Automated data platform across Hudi, Delta, and Iceberg.
Veg Capital provides Angel, Seed, and Series A capital to companies striving to replace the use of animals in the food system. All profits go to charity.
Show more...Investment focus
- Industry: Food and Beverage, Organic Food, Food Processing
- Stage:Seed, Equity Crowdfunding, Pre-Seed
- Geography: United Kingdom, Brazil, Sweden
Investor stats
- Total investments: 27
- Round size: Seed $213k–$10M; Pre-Seed $600k–$2M; Equity Crowdfunding $286k–$5.2M
- Lead/follow: 52% lead, 48% follow
Portfolio highlights
- Nutropy — Nutropy produces real milk ingredients, identical to those produced by cows, to develop premium cheese alternatives that taste just as good as cow’s cheese but are more sustainable, healthier and better for the animals. No animals involved, full cheese experience.
- VFC Foods — We took fresh, wholesome plants, worked some magic, then deep-fried them to create the most amazing Vegan Fried Chick*n.
- SHICKEN Foods — Plant-based chicken manufacturer
Grupo Ferrer International is a privately-held European R&D-based pharmaceutical company headquartered in Barcelona. It is active in the pharmaceutical, health, fine chemicals and food sectors in Europe, Latin America, Africa, the Middle East, Asia and the United States. In total, Ferrer's human health care products are commercialized inmore than 95 countries, through 24 international affiliates (including joint ventures) and 70 partners and distributors. Ferrer carries out activities throughout the full pharmaceutical value chain, from R&D to international marketing, including the fine chemical development and the manufacturing of both raw materials and finished pharmaceuticals. Its research centers in Spain and Germany, and manufacturing sites in Europe and Latin America cover the pharmaceutical, diagnostics, vaccine, fine chemical, food and feed sectors.
Show more...Investment focus
- Industry: Biotechnology, Wellness, Biopharma
- Stage:Series A
- Geography: Spain
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Venter Pharma SL — Venter Pharma is a biotech company that aims to develop products in the field of gastroenterology to help patients and professionals.It arises on the bases of some research work carried out by PhD. Juan José Aragón Reyes and Alfonso Fernández Mayoralas in the Autonomous University of Madrid and Spanish National Research Council respectively.Venter Pharma focuses on the study of solutions for digestive pathologies, with especial attention to high population prevalence disorders such as lactose intolerance or inflammatory illnesses. Venter Pharma develops innovative products to make a clinical diagnosis easier, simpler and more effective. LacTEST®, is a new diagnosic drug for the diagnosis of lactose intolerance based on a new active substance: Gaxilose
- ABAC Therapeutics — Situs resmi di Indonesia yang menghadirkan game dari PG Soft & Pragmatic Play Paling Gacor , Gampang JP Disini, surga77 memberikan akses ke permainan slot berkualitas tinggi dengan RTP yang terbukti akurat. Semua game yang disediakan di situs ini memiliki tingkat kemenangan yang transparan dan mudah diprediksi. surga77 memastikan bahwa setiap permainan dioperasikan dengan standar tertinggi dalam hal keamanan dan keadilan. Dengan berbagai fitur menarik dan berbagai pilihan permainan, pemain dapat menikmati pengalaman bermain slot yang menyenangkan dan menguntungkan. Ditambah dengan sistem transaksi yang cepat dan layanan pelanggan yang responsif, surga77 adalah tempat yang sempurna untuk para penggemar slot di Indonesia yang ingin bermain dengan nyaman.
Debiopharm invests in Smart Data & Digital Health companies developing technologies that are applicable in the areas of oncology or infectious diseases
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Seed, Pre-Seed
- Geography: Switzerland, United States, France
Investor stats
- Total investments: 41
- Round size: Seed $943k–$6M; Pre-Seed $317k–$1.7M; Series A $3.5M–$25M
- Lead/follow: 56% lead, 44% follow
Portfolio highlights
- Octozi — AI agents to accelerate clinical development workflows for the pharma industry.
- VivoSense — Scientific consulting and data analysis for wearable sensor solutions that advance clinical research.
- ModernVivo — New drugs fail in human clinical trials 90% of the time. These failures can be traced directly back to the consistent inability of preclinical animal studies to predict clinical success. Yet the design process for preclinical animal studies has remained largely unchanged for decades; scientists read a tiny fraction of published literature and writetheir experimental protocols in 2-4 weeks. This time-consuming, tedious process is not only a major pain point for in-vivo scientists but leads to substantial experimental design flaws, resulting in unreliable data with which billion-dollar decisions are made. Scientists we’ve spoken to repeatedly express their struggle with the overwhelming amount of preclinical information they need to sift through in order to design experiments. At ModernVivo, we are revolutionizing this antiquated process by equipping scientists with tools that enable them to write in-vivo protocols more effectively. Our technology empowers scientists to streamline their work, accelerating drug development timelines.
Alantra is an international financial services firm with over 500 professionals across EMEA, the Americas, and Asia.
Show more...Investment focus
- Industry: Energy, Manufacturing, Financial Services
- Stage:Private Equity, Debt Financing, Series B
- Geography: Spain, Sweden, France
Investor stats
- Total investments: 34
- Round size: Series B $16M–$28M; Debt Financing $7.7M–$39M
- Lead/follow: 44% lead, 56% follow
- Last fund: May invest from a new fund soon — raised $94M in 2021
Portfolio highlights
- enmacc — enmacc, the OTC energy trading platform, offers innovative solutions for efficient trading of energy commodities in today's dynamic market.
- SunRoof — Roof of the future
- Meteomatics — Meteomatics is a company that specializes in the specific IT needs of the weather, energy and trading industries. With more than 10 years of experience in the development of market leading forecasting systems and the rapid processing of weather data, they are happy to assist you with tailor-made solutions.
The strength of the life science industry here and the quality of its technologies. We anticipate that internationally competitive Canadian companies will do well having a fund of this size and calibre at their doorstep, and we believe such a fund will energize the sector and be a magnet for further capital."
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series C, Series A, Series B
- Geography: United States, Canada, Spain
Investor stats
- Total investments: 13
- Round size: Series A $10M–$19M; Series B $23M–$30M; Series C $20M–$72M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $500M in 2016
Portfolio highlights
- EyeYon — EyeYon Medical is an Israeli start-up company that develops innovative medical devices for the treatment of corneal edema.EyeYon Medical was founded by Dr. Daphna Ofer, a senior ophthalmologist, Dr. Arie Marcovich, a senior cornea surgeon, and Nahum Ferera, an experienced business executive. The company operates within the Van Leer TechnologyIncubator.
- Variantyx — Discover Variantyx's whole-genome sequencing diagnostics for rare genetic disorders, reproductive genetics & precision oncology. Get answers.
- CalciMedica — CalciMedica was founded in December 2006 by Gonul Velicelebi, Ph.D., Kenneth Stauderman, Ph.D. and Jack Roos, Ph.D., all previously with TorreyPines Therapeutics, where they discovered the role of STIM1 in the Icrac pathway in 2003. Other co-founders, all from the CBR Institute, include Anjana Rao, Ph.D., Patrick Hogan, Ph.D. and Stefan Feske, M.D,who identified Orai1 as the CRAC channel subunit in 2006.
Innova-Tech Consulting provides independent specialist Audio Visual and Technology consulting services.
Show more...Investment focus
- Industry: Solar, Energy, Medical
- Stage:Series A, Seed, Series B
- Geography: Canada, Spain
Investor stats
- Total investments: 5
- Round size: Series A $1.8M–$16M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- SiXtron Advanced Materials — Founded in 2004, SiXtron is a private, venture backed company located in Montreal, Quebec, focusing on developing anti-reflective coating solutions for the solar cell industry.Other highly scalable and cost-effective thin film coating solutions, for both the electronics industry and the industrial coatings sector, are under development. Sixtronthin films have unique optical and mechanical properties, and can be deposited without the complex requirements of hazardous silane gas.
- Libera Bio — Libera Bio is a biopharmaceutical company devoted to the development of a new class of therapeutics to address unmet medical needs in cancer
- Optosecurity — PAX CHECKPOINT combines automated screening lanes with a screening software to create a fully integrated checkpoint solution.
UCB Ventures is a €150 million strategic corporate venture fund
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Seed
- Geography: United States, Belgium, Spain
Investor stats
- Total investments: 21
- Round size: Seed $1.8M–$3.5M; Series A $7M–$75M; Series B $9.4M–$135M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- SonoThera — Explore therapeutic ultrasound for non-invasive, targeted genetic medicine delivery that improves precision and biodistribution. Learn more.
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
- Neurona Therapeutics — Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four neuroscientists and stem cell pioneers at The University of California, San Francisco. They are focused on the discovery and development of cell-based therapies to treat intractable neurological disease. Its initial aim is to generate therapeuticcompositions of a specific type of nerve cell (or neuron) for targeted delivery into the injured nervous system. Based on nearly two decades of research, they believe that particular subpopulations of neurons have the unique ability to integrate and repair dysregulated neural circuits. Its talented team of scientists, scientific advisors, and board directors is working to accelerate breakthrough treatments for patients with significant unmet medical needs.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 96
- Round size: Seed $2M–$6.3M; Pre-Seed $529k–$2.4M; Series A $5M–$21M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fresh fund, raised $52M in 2025
Portfolio highlights
- Biobase — Biobase is the agentic system for clinical data, closing the gap between clinical data and better healthcare.
- Ladder Health — Ladder Health offers virtual pediatric therapy and support for early childhood developmental delays, including speech and physical therapy.
- Woodway Assurance — Woodway Assurance provides EviData, an AI-driven software for automated privacy assurance on de-identified and synthetic datasets.
Life Science VC funding in Spain at a glance
Stats across 153 deals from 153 investors.
Access all 153 VC funds in Spain Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science VC Funds in Spain investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 153 VC funds investing in Spain Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!